<article><p>Malaysia&#8217;s lifesciences-focused private equity firm <a href="https://www.dealstreetasia.com/stories/asia-digest-greenlight-sentient-io-190348/">Xeraya Capital</a> has invested an undisclosed sum in the Series D round of US-based GreenLight Biosciences.</p></article>

Xeraya Capital’s investment is conducted through MLS Capital Fund II, which is co-managed with the US’ Spruce Capital Partners.

Malaysia’s Xeraya Capital invests in GreenLight Biosciences’ $102m Series D round

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

You may also like

Malaysia’s Xeraya Capital joins $120m round for US-based Rapid Micro Biosystems

Malaysia’s Xeraya Capital leads $31m Series B round for US medical device maker Aria CV

Read more from Malaysia

Editor’s take: The week that was – May 19 -24

Data Vantage: Peak XV’s partial exit from Insider and other updates